This creates a situation in which patients with certain comorbidities have access, while others with similar weight-related risks do not
If you are currently on a compounded GLP-1 or are considering starting medical weight loss, we are happy to discuss your options and determine the safest path forward
Among its findings: Protandim increased the median lifespan of male mice by 7% which the paper characterized as a small but statistically significant change that wasnt seen in female mice
Seniors, for example, cant even get a prescription benefit in Part D for AOMs and obesity medication. The promotional campaign around Wegovy, offering virtual training sessions for 5,000 HCPs and the creation of an educational website called Rethink Obesity, looks however to have played a big part in combating the negative thinking around the disease
Need help choosing the right product
Third, use clear, nontechnical language